搜索临床试验以:FGF-23, endothelial dysfunction, sevelamer
总计7093个结果
-
Gustave Roussy, Cancer Campus, Grand Paris完全的
-
Liverpool School of Tropical MedicineFred Hutchinson Cancer Center; University of Oxford; University of Liverpool; Malawi-Liverpool-Wellcome... 和其他合作者尚未招聘
-
Sun Pharmaceutical Industries Limited招聘中
-
Astellas Pharma Europe B.V.Veeda Clinical Research完全的
-
University of WashingtonNational Cancer Institute (NCI); University of Wisconsin, Madison主动,不招人II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | HER2/Neu 阴性 | III期乳腺癌 | 无疾病迹象 | 一个或多个腋窝淋巴结阳性美国
-
mAbxience Research S.L.招聘中
-
University of WashingtonNational Cancer Institute (NCI); University of Wisconsin, Madison招聘中解剖学 IB 期乳腺癌 AJCC v8 | 解剖学 II 期乳腺癌 AJCC v8 | 解剖学 IIA 期乳腺癌 AJCC v8 | 解剖学 IIB 期乳腺癌 AJCC v8 | 解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 IB 期乳腺癌 AJCC v8 | 预后 II 期乳腺癌 AJCC v8 | 预后 IIA 期乳腺癌 AJCC v8 | 预后 IIB 期乳腺癌 AJCC v8 | 预后 III 期乳腺癌 AJCC v8 | 预后 IIIA 期乳腺癌 AJCC v8 | 预后 IIIB 期乳腺癌 AJCC v8 及其他条件美国
-
Singapore National Eye CentreSingapore Eye Research Institute; Nanchang University完全的
-
Solvay PharmaceuticalsNektar Therapeutics完全的
-
Merck Sharp & Dohme LLCEisai Inc.主动,不招人胶质母细胞瘤 | 胃癌 | 大肠癌 | 胰腺癌 | 卵巢癌 | 晚期实体瘤 | 三阴性乳腺癌 | 胆道癌美国, 阿根廷, 澳大利亚, 加拿大, 智利, 哥伦比亚, 法国, 德国, 以色列, 意大利, 大韩民国, 俄罗斯联邦, 西班牙, 瑞士, 台湾, 泰国, 英国
-
University Health Network, TorontoCanadian Institutes of Health Research (CIHR)招聘中
-
Weill Medical College of Cornell UniversityAngiocrine Bioscience尚未招聘
-
National Institute of Allergy and Infectious Diseases...尚未招聘
-
Istituti Clinici Scientifici Maugeri SpA尚未招聘
-
The University of Texas Medical Branch, Galveston招聘中
-
Sultan Abdulhamid Han Training and Research Hospital...招聘中
-
Unity Health TorontoUniversity of Ottawa; Toronto Metropolitan University尚未招聘
-
University of California, San FranciscoAmerican Society of Transplantation招聘中